MicroPort NeuroScientific Corporation (HKG:2172)
Hong Kong · Delayed Price · Currency is HKD 8.68
-0.08 (-0.91%)
Aug 21, 2026, 4:08 PM HKT
MicroPort NeuroScientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 790.48 | 761.76 | 665.62 | 547.35 | 382.8 | |
Revenue Growth | 3.77% | 14.44% | 21.61% | 42.99% | 72.49% |
Cost of Revenue | 209.76 | 205.84 | 153.83 | 154.35 | 84.45 |
Gross Profit | 580.72 | 555.93 | 511.79 | 393 | 298.35 |
Selling, General & Admin | 230.79 | 188.3 | 166.87 | 154.46 | 116.47 |
Research & Development | 77.92 | 96.48 | 165.13 | 123.27 | 94.13 |
Other Operating Expenses | -33.94 | -28.7 | -18.67 | -18 | -20.11 |
Operating Expenses | 274.76 | 256.09 | 313.34 | 259.72 | 190.5 |
Operating Income | 305.96 | 299.84 | 198.46 | 133.28 | 107.86 |
Interest Expense | -1.18 | -2.32 | -3.46 | -99.28 | -45.2 |
Interest & Investment Income | 15.6 | 15.87 | 16.57 | 9.97 | 3.96 |
Earnings From Equity Investments | -25.35 | -20.56 | -23.84 | -26.62 | -7.52 |
Currency Exchange Gain (Loss) | 1.11 | 0.43 | -0.64 | -0.54 | -0.16 |
Other Non Operating Income (Expenses) | -0.42 | -1.22 | -0.27 | -0.15 | -0.11 |
EBT Excluding Unusual Items | 295.73 | 292.05 | 186.82 | 16.67 | 58.83 |
Merger & Restructuring Charges | - | - | - | - | -0.98 |
Gain (Loss) on Sale of Investments | -64.75 | 10.32 | -24.63 | 1.7 | - |
Gain (Loss) on Sale of Assets | - | 0.37 | -0.13 | -0.03 | 0.39 |
Other Unusual Items | - | - | - | -22.66 | -26.34 |
Pretax Income | 230.98 | 302.73 | 162.05 | -4.33 | 31.9 |
Income Tax Expense | 47.23 | 53.88 | 27.47 | 20.35 | 7.73 |
Earnings From Continuing Operations | 183.75 | 248.86 | 134.58 | -24.68 | 24.17 |
Minority Interest in Earnings | 0.76 | 5.31 | 10.97 | 2.91 | - |
Net Income | 184.51 | 254.17 | 145.55 | -21.77 | 24.17 |
Net Income to Common | 184.51 | 254.17 | 145.55 | -21.77 | 24.17 |
Net Income Growth | -27.41% | 74.63% | - | - | -46.63% |
Shares Outstanding (Basic) | 571 | 579 | 583 | 518 | 495 |
Shares Outstanding (Diluted) | 571 | 579 | 583 | 518 | 495 |
Shares Change | -1.39% | -0.62% | 12.58% | 4.46% | 8.76% |
EPS (Basic) | 0.32 | 0.44 | 0.25 | -0.04 | 0.05 |
EPS (Diluted) | 0.32 | 0.44 | 0.25 | -0.04 | 0.05 |
EPS Growth | -27.10% | 75.71% | - | - | -50.93% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 182.3 | 275.54 | 140.93 | 191.53 | 107.97 |
Free Cash Flow Per Share | 0.32 | 0.48 | 0.24 | 0.37 | 0.22 |
Dividend Per Share | 0.126 | 0.179 | 0.100 | - | - |
Dividend Growth | -29.54% | 78.81% | - | - | - |
Gross Margin | 73.46% | 72.98% | 76.89% | 71.80% | 77.94% |
Operating Margin | 38.70% | 39.36% | 29.82% | 24.35% | 28.18% |
Profit Margin | 23.34% | 33.37% | 21.87% | -3.98% | 6.31% |
Free Cash Flow Margin | 23.06% | 36.17% | 21.17% | 34.99% | 28.21% |
EBITDA | 340.13 | 334.4 | 214.04 | 175.46 | 128.47 |
EBITDA Margin | 43.03% | 43.90% | 32.16% | 32.06% | 33.56% |
D&A For EBITDA | 34.17 | 34.56 | 15.58 | 42.18 | 20.61 |
EBIT | 305.96 | 299.84 | 198.46 | 133.28 | 107.86 |
EBIT Margin | 38.70% | 39.36% | 29.82% | 24.35% | 28.18% |
Effective Tax Rate | 20.45% | 17.80% | 16.95% | - | 24.24% |